Eisai Co Ltd
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Eisai Co Ltd is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Eisai Co Ltd in the same report. This provides an indication of potential competitors or associated to Eisai Co Ltd. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Cerebral (Fatal) Malaria - Pipeline Review, H2 2016

Cerebral (Fatal) Malaria - Pipeline Review, H2 2016


2016-12-30
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral (Fatal) Malaria – Pipeline Review, H2 2016, provides an overview of the Cerebral (Fatal) Malaria (Infectious Disease) pipeline landscape.

Cerebral...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8915IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8915IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016

    Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H2, 2016" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3952CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3952CTIDB
  • View Report: Research and Experts Market Report: Chronic Liver Disease Global Clinical Trials Review, H2, 2016

    Chronic Liver Disease Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3940CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3940CTIDB
  • View Report: Research and Experts Market Report: Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016

    Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H2, 2016" provides an overview of Functional (Non Ulcer) Dyspepsia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3937CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3937CTIDB
  • View Report: Research and Experts Market Report: Esophageal Diseases Global Clinical Trials Review, H2, 2016

    Esophageal Diseases Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Esophageal Diseases Global Clinical Trials Review, H2, 2016" provides an overview of Esophageal Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3936CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3936CTIDB
  • View Report: Research and Experts Market Report: Gastric Ulcers Global Clinical Trials Review, H2, 2016

    Gastric Ulcers Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastric Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Gastric Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3931CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3931CTIDB
  • View Report: Research and Experts Market Report: Gastritis Global Clinical Trials Review, H2, 2016

    Gastritis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastritis Global Clinical Trials Review, H2, 2016" provides an overview of Gastritis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastritis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3925CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3925CTIDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Project Profile: EISA - Pando Monte Lirio Hydroelectric Power Plant 84 MW - Chiriqui - Construction Project Profile

    EISA - Pando Monte Lirio Hydroelectric Power Plant 84 MW - Chiriqui - Construction Project Profile


    2016-11-30
    Timetric's "EISA – Pando Monte Lirio Hydroelectric Power Plant 84 MW – Chiriqui - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the EISA –...
  • Project Profile
  • Manufacturing and Construction
  • Panama
  • $75.00
  • Report 00RV-CIC132800PP has a star rating of 4.1 out of 5
  • Go to More information on Report 00RV-CIC132800PP
  • View Report: Research and Experts Market Report: Dystonia Global Clinical Trials Review, H2, 2016

    Dystonia Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H2, 2016" provides an overview of Dystonia clinical trials scenario. This report provides top line data relating to the clinical trials on Dystonia. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3912CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3912CTIDB
  • View Report: Research and Experts Market Report: Esophagitis Global Clinical Trials Review, H2, 2016

    Esophagitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Esophagitis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3905CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3905CTIDB
  • View Report: Research and Experts Market Report: Acidity Global Clinical Trials Review, H2, 2016

    Acidity Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Acidity Global Clinical Trials Review, H2, 2016" provides an overview of Acidity clinical trials scenario. This report provides top line data relating to the clinical trials on Acidity. Report includes...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3893CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3893CTIDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Medullary Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3877CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3877CTIDB
  • View Report: Research and Experts Market Report: Thymic Carcinoma Global Clinical Trials Review, H2, 2016

    Thymic Carcinoma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3876CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3876CTIDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016

    Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Recurrent Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3874CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3874CTIDB
  • View Report: Research and Experts Market Report: Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase...

    Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0673TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0673TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Lennox-Gastaut Syndrome - Pipeline Review, H2 2016

    Lennox-Gastaut Syndrome - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lennox-Gastaut Syndrome – Pipeline Review, H2 2016, provides an overview of the Lennox-Gastaut Syndrome (Central Nervous System) pipeline landscape.

    Lennox-Gastaut...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8798IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8798IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Round Cell Liposarcoma Global Clinical Trials Review, H2, 2016

    Round Cell Liposarcoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Round Cell Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Round Cell Liposarcoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3868CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3868CTIDB
  • View Report: Research and Experts Market Report: Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3865CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3865CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3863CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3863CTIDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0635TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0635TDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2016

    Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis – Pipeline Review, H2 2016, provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape.

    Amyo...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8730IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8730IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Market Report: Dyskinesia Global Clinical Trials Review, H2, 2016

    Dyskinesia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H2, 2016" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3847CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3847CTIDB
  • View Report: Research and Experts Market Report: Delirium Global Clinical Trials Review, H2, 2016

    Delirium Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, H2, 2016" provides an overview of Delirium clinical trials scenario. This report provides top line data relating to the clinical trials on Delirium. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3846CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3846CTIDB
  • View Report: Research and Experts Market Report: Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016

    Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2016" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3837CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3837CTIDB
  • View Report: Research and Experts Market Report: Dyspepsia Global Clinical Trials Review, H2, 2016

    Dyspepsia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2016" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3835CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3835CTIDB
  • View Report: Research and Experts Market Report: Hepatic Encephalopathy Global Clinical Trials Review, H2, 2016

    Hepatic Encephalopathy Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H2, 2016" provides an overview of Hepatic Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3834CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3834CTIDB
  • View Report: Research and Experts Project Profile: Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report

    Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report


    2017-01-31
    Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid...
  • Project Profile
  • Life Sciences
  • Japan
  • $175.00
  • Report 05IK-F309772E-1A3A-40B6-9836-90 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-F309772E-1A3A-40B6-9836-90
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2016

    Cervical Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H2 2016, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.

    Cervical cancer occurs when abnormal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8700IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8700IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H2 2016

    Endometrial Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape.

    Endometrial cancer is cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8689IDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016

    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0586TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0586TDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H2 2016

    Malaria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

    Malaria is a life-threatening blood disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8670IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8670IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Oral Mucositis Global Clinical Trials Review, H2, 2016

    Oral Mucositis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Oral Mucositis Global Clinical Trials Review, H2, 2016" provides an overview of Oral Mucositis clinical trials scenario. This report provides top line data relating to the clinical trials on Oral Mucositis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3804CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3804CTIDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016

    Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H2 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0584TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0584TDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H2 2016

    Insomnia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insomnia – Pipeline Review, H2 2016, provides an overview of the Insomnia (Central Nervous System) pipeline landscape.

    Insomnia is a sleep disorder that is...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8636IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8636IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Paralysis Global Clinical Trials Review, H2, 2016

    Paralysis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H2, 2016" provides an overview of Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Paralysis. Report...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3780CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3780CTIDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2016

    Fallopian Tube Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer – Pipeline Review, H2 2016, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.

    Fallopian tube cancer is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8595IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8595IDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia Associated With Alzheimer's Disease – Pipeline Review, H2 2016, provides an overview of the Dementia Associated With Alzheimer's Disease (Central...
  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8589IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8589IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Ureter Cancer - Pipeline Review, H2 2016

    Ureter Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ureter Cancer – Pipeline Review, H2 2016, provides an overview of the Ureter Cancer (Oncology) pipeline landscape.

    Ureter cancer or ureteral cancer is cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8565IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8565IDB
  • View Report: Research and Experts Market Report: Metastatic Ovarian Cancer - Pipeline Review, H2 2016

    Metastatic Ovarian Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Ovarian Cancer (Oncology) pipeline landscape.

    Metastatic ovarian...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8564IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8564IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2016

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease – Pipeline Review, H2 2016, provides an overview of the Chagas Disease (Infectious Disease) pipeline landscape.

    Chagas disease or American Trypanosomi...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8523IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8523IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2016

    Mild Cognitive Impairment - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment – Pipeline Review, H2 2016, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape.

    Mild...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8518IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8518IDB
  • View Report: Research and Experts Market Report: Peptic Ulcers Global Clinical Trials Review, H2, 2016

    Peptic Ulcers Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Peptic Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Peptic Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Peptic Ulcers....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3747CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3747CTIDB
  • View Report: Research and Experts Market Report: Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016

    Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016’, provides in depth analysis on Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0543TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0543TDB
  • View Report: Research and Experts Market Report: Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2016

    Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H2 2016’, provides in depth analysis on Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0542TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0542TDB
  • View Report: Research and Experts Market Report: Lewy body Dementia - Pipeline Review, H2 2016

    Lewy body Dementia - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lewy body Dementia - Pipeline Review, H2 2016’, provides an overview of the Lewy body Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lewy...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8506IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8506IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Market Report: Supratentorial Glioma Global Clinical Trials Review, H2, 2016

    Supratentorial Glioma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Supratentorial Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Supratentorial Glioma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3733CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3733CTIDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

    Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3732CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3732CTIDB
  • View Report: Research and Experts Market Report: Mycosis Fungoides Global Clinical Trials Review, H2, 2016

    Mycosis Fungoides Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3729CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3729CTIDB
  • View Report: Research and Experts Market Report: Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

    Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of Natural Killer Cell Lymphomas clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3727CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3727CTIDB
  • View Report: Research and Experts Market Report: T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

    T-Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3718CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3718CTIDB
  • View Report: Research and Experts Market Report: Vertigo Global Clinical Trials Review, H2, 2016

    Vertigo Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Vertigo Global Clinical Trials Review, H2, 2016" provides an overview of Vertigo clinical trials scenario. This report provides top line data relating to the clinical trials on Vertigo. Report includes...
  • Market Report
  • Ear Nose Throat Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3692CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3692CTIDB
  • View Report: Research and Experts Market Report: Insomnia - Current and Future Players

    Insomnia - Current and Future Players


    2015-02-27
    GlobalData has released its pharma report, “Insomnia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1062FPR has a star rating of 3.3 out of 5
  • Go to More information on Report 05IC-GDHC1062FPR
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2016

    Arterial Thrombosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8444IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8444IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8436IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8436IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H2 2016

    Anxiety Disorders - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8433IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8433IDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016’, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8419IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8419IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016

    Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016" provides an overview of Chagas Disease (American Trypanosomiasis) clinical trials scenario. This report provides top...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3659CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3659CTIDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2016

    Epilepsy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8401IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8401IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2016

    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2016’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8395IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8395IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8355IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8355IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H2 2016

    Dementia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Dementia - Pipeline Review, H2 2016’, provides an overview of the Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8345IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8345IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8339IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8339IDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-07-27
    ‘Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in depth analysis on Poly [ADP Ribose]...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0412TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0412TDB
  • View Report: Research and Experts Market Report: Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2)...

    Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Dual Specificity Mitogen Activated Protein Kinase Kinase 1 (ERK Activator Kinase 1 or MAPK/ERK Kinase 1 or MAP2K1 or EC 2.7.12.2) - Pipeline Review, H2 2016’, provides in depth analysis on Dual Specificity Mitogen Activated Protein Kinase Kinase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0405TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0405TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2016

    Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2016


    2016-07-20
    ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2016’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Onychomycosis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8285IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8285IDB
  • View Report: Research and Experts Market Report: Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2016

    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2016


    2016-07-20
    ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8242IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8242IDB
  • View Report: Research and Experts Market Report: Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2016

    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2016


    2016-07-27
    ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2016’, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8310IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8310IDB
  • View Report: Research and Experts Market Report: Seizures - Pipeline Review, H2 2016

    Seizures - Pipeline Review, H2 2016


    2016-07-20
    ‘Seizures - Pipeline Review, H2 2016’, provides an overview of the Seizures pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Seizures, complete with analysis by stage of development,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8290IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8290IDB
  • View Report: Research and Experts Company Reports: Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review

    Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review


    2016-08-17
    Sunesis Pharmaceuticals, Inc. (Sunesis), formerly Mosaic Pharmaceuticals, Inc., is a biopharmaceutical company. It develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's lead product candidate Qinpr...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 01B4-GDPH33264FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 01B4-GDPH33264FSA
  • View Report: Research and Experts Market Report: Down Syndrome - Pipeline Review, H2 2016

    Down Syndrome - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H2 2016’, provides an overview of the Down Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Down Syndrome,...

  • Market Report
  • Genetic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8271IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8271IDB
  • View Report: Research and Experts Market Report: Lewy body Dementia Global Clinical Trials Review, H1, 2016

    Lewy body Dementia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Lewy body Dementia Global Clinical Trials Review, H1, 2016" provides an overview of Lewy body Dementia clinical trials scenario. This report provides top line data relating to the clinical trials on Lewy body Dementia....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3545CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3545CTIDB
  • View Report: Research and Experts Market Report: Partial Seizure Global Clinical Trials Review, H1, 2016

    Partial Seizure Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Partial Seizure Global Clinical Trials Review, H1, 2016" provides an overview of Partial Seizure clinical trials scenario. This report provides top line data relating to the clinical trials on Partial Seizure. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3538CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3538CTIDB
  • View Report: Research and Experts Market Report: Myoclonic Seizure Global Clinical Trials Review, H1, 2016

    Myoclonic Seizure Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Myoclonic Seizure Global Clinical Trials Review, H1, 2016" provides an overview of Myoclonic Seizure clinical trials scenario. This report provides top line data relating to the clinical trials on Myoclonic Seizure. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3535CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3535CTIDB
  • View Report: Research and Experts Market Report: Insomnia Global Clinical Trials Review, H1, 2016

    Insomnia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Insomnia Global Clinical Trials Review, H1, 2016" provides an overview of Insomnia clinical trials scenario. This report provides top line data relating to the clinical trials on Insomnia. Report includes an overview...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3533CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3533CTIDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016

    Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Mild Cognitive Impairment Global Clinical Trials Review, H1, 2016" provides an overview of Mild Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Mild...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3523CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3523CTIDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2016" provides an overview of Dementia Associated With Alzheimer's Disease clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3521CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3521CTIDB
  • View Report: Research and Experts Market Report: Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase...

    Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016’, provides in depth analysis...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0248TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0248TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24)...

    Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24) - Pipeline Review, H1 2016’, provides in depth analysis on Mitogen-Activated Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0220TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0220TDB
  • View Report: Research and Experts Market Report: Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016

    Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Toll Like Receptor 4 (CD284 or TLR4) - Pipeline Review, H1 2016’, provides in depth analysis on Toll Like Receptor 4 (CD284 or TLR4) targeted pipeline therapeutics.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0189TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0189TDB
  • View Report: Research and Experts Market Report: Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016

    Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c-Mpl or CD110 or MPL) - Pipeline Review, H1 2016’, provides in depth analysis on Thrombopoietin Receptor (Myeloproliferative Leukemia...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0183TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0183TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016

    Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Glucocorticoid-Induced Osteoporosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3508CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3508CTIDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023

    PharmaPoint: Renal Cell Carcinoma - Global Drug Forecast and Market Analysis to 2023


    2016-04-21
    Renal cell carcinoma (RCC) is among the 10 most frequently occurring cancers in Western countries. The RCC market is currently dominated by anti-angiogenic agents and tyrosine kinase inhibitors (TKIs) in particular, but it will experience dramatic changes...
  • Market Report
  • Oncology
  • Global
  • $10,995.00
  • Report 05IC-GDHC88PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC88PIDR
  • View Report: Research and Experts Market Report: Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT...

    Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0105TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0105TDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016

    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0094TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0094TDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: High-Grade Glioma Global Clinical Trials Review, H1, 2016

    High-Grade Glioma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H1, 2016" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3476CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3476CTIDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016

    Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3446CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3446CTIDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3443CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3443CTIDB
  • View Report: Research and Experts Market Report: Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016

    Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016’, provides in depth analysis on Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0088TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0088TDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2016

    Multiple Sclerosis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Multiple...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7962IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7962IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H1 2016

    Neuroendocrine Tumors - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2016’, provides an overview of the Neuroendocrine Tumors pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8174IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8174IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Lennox-Gastaut Syndrome - Pipeline Review, H1 2016

    Lennox-Gastaut Syndrome - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Lennox-Gastaut Syndrome - Pipeline Review, H1 2016’, provides an overview of the Lennox-Gastaut Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8153IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8153IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016

    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Amyotrophic Lateral Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7974IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7974IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Vascular Dementias Global Clinical Trials Review, H1, 2016

    Vascular Dementias Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Vascular Dementias Global Clinical Trials Review, H1, 2016" provides an overview of Vascular Dementias clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3410CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3410CTIDB
  • View Report: Research and Experts Market Report: Endometrial Cancer Global Clinical Trials Review, H1, 2016

    Endometrial Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3399CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3399CTIDB
  • View Report: Research and Experts Market Report: Thyroid Cancer Global Clinical Trials Review, H1, 2016

    Thyroid Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3396CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3396CTIDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H1 2016

    Cervical Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2016’, provides an overview of the Cervical Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cervical Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7994IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7994IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Orexin Receptor Type 2 (Ox2R or Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H1 2016

    Orexin Receptor Type 2 (Ox2R or Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Orexin Receptor Type 2 (Ox2R or Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H1 2016’, provides in depth analysis on Orexin Receptor Type 2 (Ox2R or Hypocretin Receptor Type 2 or HCRTR2) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0031TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0031TDB
  • View Report: Research and Experts Market Report: Orexin Receptor Type 1 (Ox-1-R or Ox1R or Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H1 2016

    Orexin Receptor Type 1 (Ox-1-R or Ox1R or Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Orexin Receptor Type 1 (Ox-1-R or Ox1R or Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H1 2016’, provides in depth analysis on Orexin Receptor Type 1 (Ox-1-R or Ox1R or Hypocretin Receptor Type 1 or...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0030TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0030TDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2016

    Thrombocytopenia - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2016’, provides an overview of the Thrombocytopenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thrombocytopenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8023IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8023IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2016

    Endometrial Cancer - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2016’, provides an overview of the Endometrial Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometrial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8014IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8014IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2016

    Malaria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2016’, provides an overview of the Malaria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7969IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7969IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H1 2016

    Insomnia - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2016’, provides an overview of the Insomnia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Insomnia, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8039IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8039IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Nausea and Vomiting clinical trials scenario. This report provides top line...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3386CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3386CTIDB
  • View Report: Research and Experts Market Report: Aphasia Global Clinical Trials Review, H1, 2016

    Aphasia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Aphasia Global Clinical Trials Review, H1, 2016" provides an overview of Aphasia clinical trials scenario. This report provides top line data relating to the clinical trials on Aphasia. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3370CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3370CTIDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016’, provides an overview of the Dementia Associated With Alzheimer's Disease pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7887IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7887IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Septic Shock Global Clinical Trials Review, H1, 2016

    Septic Shock Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Septic Shock Global Clinical Trials Review, H1, 2016" provides an overview of Septic Shock clinical trials scenario. This report provides top line data relating to the clinical trials on Septic Shock....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3348CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3348CTIDB
  • View Report: Research and Experts Market Report: Ureter Cancer - Pipeline Review, H1 2016

    Ureter Cancer - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H1 2016’, provides an overview of the Ureter Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ureter Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7934IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7934IDB
  • View Report: Research and Experts Market Report: Metastatic Ovarian Cancer - Pipeline Review, H1 2016

    Metastatic Ovarian Cancer - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7892IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7892IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2016

    Mild Cognitive Impairment - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7841IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7841IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7838IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7838IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H1 2016

    Hypersensitivity - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H1 2016’, provides an overview of the Hypersensitivity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypersensitivity,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7901IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7901IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2016

    Depression - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2016’, provides an overview of the Depression pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Depression, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7581IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7581IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2016

    Arterial Thrombosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7739IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7739IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7729IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7729IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2016

    Anxiety Disorders - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7698IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7698IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

    Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3328CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3328CTIDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016

    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7733IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7733IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7732IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7732IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H1 2016

    Epilepsy - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2016’, provides an overview of the Epilepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Epilepsy, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7565IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7565IDB
  • View Report: Research and Experts Market Report: Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2016

    Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Lennox-Gastaut Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3302CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3302CTIDB
  • View Report: Research and Experts Market Report: Dystonia Global Clinical Trials Review, H1, 2016

    Dystonia Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2016" provides an overview of Dystonia clinical trials scenario. This report provides top line data relating to the clinical trials on Dystonia. Report includes...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3300CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3300CTIDB
  • View Report: Research and Experts Market Report: Dyskinesia Global Clinical Trials Review, H1, 2016

    Dyskinesia Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2016" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3291CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3291CTIDB
  • View Report: Research and Experts Market Report: Delirium Global Clinical Trials Review, H1, 2016

    Delirium Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, H1, 2016" provides an overview of Delirium clinical trials scenario. This report provides top line data relating to the clinical trials on Delirium. Report includes...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3290CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3290CTIDB
  • View Report: Research and Experts Market Report: Duodenal Ulcer Global Clinical Trials Review, H1, 2016

    Duodenal Ulcer Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Duodenal Ulcer Global Clinical Trials Review, H1, 2016" provides an overview of Duodenal Ulcer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3286CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3286CTIDB
  • View Report: Research and Experts Market Report: Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016

    Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Zollinger-Ellison Syndrome (Gastrinoma) clinical trials scenario. This report provides top line...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3276CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3276CTIDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Trypanosomiasis Global Clinical Trials Review, H1, 2016

    Trypanosomiasis Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H1, 2016" provides an overview of Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trypanosomiasis...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3255CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3255CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024


    2015-12-22
    Glioblastoma multiforme (GBM) is characterized as a disease with some of the highest unmet needs in oncology, with patients having a median overall survival (OS) of between one and two years. The lack of therapies is primarily due to the inability of...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC053POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC053POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Company Reports: Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile

    Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Reports
  • Medical Devices
  • Japan
  • $250.00
  • Report 05IB-GDME27458D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME27458D
  • View Report: Research and Experts Company Reports: Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review

    Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review


    2016-02-23
    Sunesis Pharmaceuticals, Inc. (Sunesis), formerly Mosaic Pharmaceuticals, Inc., is a biopharmaceutical company. It develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's lead product candidate vosar...
  • Company Reports
  • Construction Materials
  • United States
  • $125.00
  • Report 05IB-GDPH33264FSA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GDPH33264FSA
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7660IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7660IDB
  • View Report: Research and Experts Market Report: Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2016

    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2016’, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7597IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7597IDB
  • View Report: Research and Experts Market Report: Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2016

    Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2016’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7631IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7631IDB
  • View Report: Research and Experts Market Report: Down Syndrome - Pipeline Review, H1 2016

    Down Syndrome - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H1 2016’, provides an overview of the Down Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Down Syndrome,...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7605IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7605IDB
  • View Report: Research and Experts Market Report: Seizures - Pipeline Review, H1 2016

    Seizures - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Seizures - Pipeline Review, H1 2016’, provides an overview of the Seizures pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Seizures, complete with analysis...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7566IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7566IDB
  • View Report: Research and Experts Market Report: Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016

    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7632IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7632IDB
  • View Report: Research and Experts Market Report: Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2016

    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2016’, provides an overview of the Functional (Non Ulcer) Dyspepsia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7596IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7596IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Sjögren

    OpportunityAnalyzer: Sjögren's Syndrome - Opportunity Analysis and Forecast to 2024


    2015-12-19
    Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary glands, resulting...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC048POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC048POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024


    2015-12-17
    Liver cancer is the second leading cause of cancer related death in the world in men and the sixth leading cause of cancer death in women. Hepatocellular carcinoma (HCC) is the most dominant form of liver cancer, accounting for approximately 85% of liver...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC046POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC046POA
  • View Report: Research and Experts Market Report: Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016

    Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2016" provides an overview of Acid Indigestion / Heartburn/ Pyrosis clinical trials scenario. This report provides top line data...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3229CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3229CTIDB
  • View Report: Research and Experts Market Report: Melanoma Global Clinical Trials Review, H1, 2016

    Melanoma Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Melanoma Global Clinical Trials Review, H1, 2016" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3214CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3214CTIDB
  • View Report: Research and Experts Market Report: Sezary Syndrome Global Clinical Trials Review, H1, 2016

    Sezary Syndrome Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3210CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3210CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023

    OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023


    2015-12-01
    The main drivers of growth in graft versus host disease over the 2013-2023 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM.

    Sa...

  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC014EPOA has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC014EPOA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024


    2015-12-01
    Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC051POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC051POA
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H2 2015

    Epilepsy - Pipeline Review, H2 2015


    2015-11-11
    Epilepsy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7401IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7401IDB
  • View Report: Research and Experts Market Report: Metastatic Ovarian Cancer - Pipeline Review, H2 2015

    Metastatic Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7259IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7259IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015


    2015-10-30
    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015’, provides an overview of the Chagas Disease (American Trypanosomiasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7235IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7235IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2015

    Cervical Cancer - Pipeline Review, H2 2015


    2015-10-30
    Cervical Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H2 2015’, provides an overview of the Cervical Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7210IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7210IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-21
    Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6843IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6843IDB
  • View Report: Research and Experts Market Report: Candidiasis - Pipeline Review, H2 2015

    Candidiasis - Pipeline Review, H2 2015


    2015-10-21
    Candidiasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H2 2015’, provides an overview of the Candidiasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6842IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6842IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H2 2015

    Dementia - Pipeline Review, H2 2015


    2015-10-21
    Dementia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Dementia - Pipeline Review, H2 2015’, provides an overview of the Dementia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6839IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6839IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Seizures - Pipeline Review, H2 2015

    Seizures - Pipeline Review, H2 2015


    2015-09-30
    Seizures - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Seizures - Pipeline Review, H2 2015’, provides an overview of the Seizures’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6968IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6968IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015


    2015-09-23
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7083IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7083IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2015

    Arterial Thrombosis - Pipeline Review, H2 2015


    2015-09-16
    Arterial Thrombosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7120IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC7120IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015

    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015


    2015-09-16
    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Chemotherapy Induced Peripheral...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7119IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7119IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015


    2015-09-16
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7108IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7108IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015

    Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015


    2015-09-16
    Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7095IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7095IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2015

    Mild Cognitive Impairment - Pipeline Review, H2 2015


    2015-08-31
    Mild Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mild cognitive impairment - Pipeline Review, H2 2015’, provides an overview of the Mild cognitive impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7058IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7058IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015


    2015-08-31
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6990IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6990IDB
  • View Report: Research and Experts Market Report: Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2015

    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2015


    2015-08-31
    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2015’, provides an overview of the Reflux Esophagitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6986IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6986IDB
  • View Report: Research and Experts Market Report: Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2015

    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2015


    2015-08-26
    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2015’, provides an overview of the Functional (Non Ulcer) Dyspepsia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7022IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC7022IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Down Syndrome - Pipeline Review, H2 2015

    Down Syndrome - Pipeline Review, H2 2015


    2015-08-19
    Down Syndrome - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H2 2015’, provides an overview of the Down Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7008IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC7008IDB
  • View Report: Research and Experts Market Report: Follicular Thyroid Cancer - Pipeline Review, H2 2015

    Follicular Thyroid Cancer - Pipeline Review, H2 2015


    2015-07-31
    Follicular Thyroid Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Follicular Thyroid Cancer - Pipeline Review, H2 2015’, provides an overview of the Follicular Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6926IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6926IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Malignant Glioma - Pipeline Review, H2 2015

    Malignant Glioma - Pipeline Review, H2 2015


    2015-07-31
    Malignant Glioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6872IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6872IDB
  • View Report: Research and Experts Market Report: Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2015

    Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2015


    2015-07-31
    Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6868IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6868IDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H2 2015

    Recurrent Malignant Glioma - Pipeline Review, H2 2015


    2015-07-29
    Recurrent Malignant Glioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H2 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6884IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6884IDB
  • View Report: Research and Experts Market Report: Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015


    2015-07-29
    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2015’, provides an overview of the Elephantiasis (Lymphatic Filariasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6883IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6883IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2015

    Multiple Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Multiple Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6497IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6497IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2015

    Malaria - Pipeline Review, H1 2015


    2015-06-30
    Malaria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6677IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6677IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2015

    Tuberculosis - Pipeline Review, H1 2015


    2015-06-30
    Tuberculosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6566IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6566IDB
  • View Report: Research and Experts Market Report: Thrombosis - Pipeline Review, H1 2015

    Thrombosis - Pipeline Review, H1 2015


    2015-06-30
    Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6511IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6511IDB
  • View Report: Research and Experts Market Report: Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Amyotrophic Lateral Sclerosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6508IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6508IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H1 2015

    Atopic Dermatitis - Pipeline Review, H1 2015


    2015-06-30
    Atopic Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Atopic Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6513IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6513IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6516IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6516IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2015

    Thrombocytopenia - Pipeline Review, H1 2015


    2015-06-24
    Thrombocytopenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2015’, provides an overview of the Thrombocytopenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6698IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6698IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2015

    Follicular Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Follicular Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6690IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6690IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Low Back Pain - Pipeline Review, H1 2015

    Low Back Pain - Pipeline Review, H1 2015


    2015-06-10
    Low Back Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Low Back Pain - Pipeline Review, H1 2015’, provides an overview of the Low Back Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6717IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6717IDB
  • View Report: Research and Experts Market Report: Insomnia - Pipeline Review, H1 2015

    Insomnia - Pipeline Review, H1 2015


    2015-06-10
    Insomnia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Insomnia - Pipeline Review, H1 2015’, provides an overview of the Insomnia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6711IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6711IDB
  • View Report: Research and Experts Market Report: Aspergillosis - Pipeline Review, H1 2015

    Aspergillosis - Pipeline Review, H1 2015


    2015-06-10
    Aspergillosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H1 2015’, provides an overview of the Aspergillosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6708IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6708IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2015

    Endometrial Cancer - Pipeline Review, H1 2015


    2015-05-29
    Endometrial Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6584IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6584IDB
  • View Report: Research and Experts Market Report: Malignant Mesothelioma - Pipeline Review, H1 2015

    Malignant Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6582IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6582IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Lung Adenocarcinoma - Pipeline Review, H1 2015

    Lung Adenocarcinoma - Pipeline Review, H1 2015


    2015-05-29
    Lung Adenocarcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H1 2015’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6718IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6718IDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H1 2015

    Hypersensitivity - Pipeline Review, H1 2015


    2015-05-20
    Hypersensitivity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H1 2015’, provides an overview of the Hypersensitivity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6748IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6748IDB
  • View Report: Research and Experts Market Report: Partial Seizure - Pipeline Review, H1 2015

    Partial Seizure - Pipeline Review, H1 2015


    2015-05-20
    Partial Seizure - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H1 2015’, provides an overview of the Partial Seizure’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6731IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6731IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2015

    Mild Cognitive Impairment - Pipeline Review, H1 2015


    2015-04-30
    Mild Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Mild Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6544IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6544IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015


    2015-04-30
    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015’, provides an overview of the Chagas Disease (American Trypanosomiasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6540IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6540IDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015


    2015-04-29
    Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Dementia Associated...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6632IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6632IDB
  • View Report: Research and Experts Market Report: Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Venous (Vein) Thrombosis - Pipeline Review, H1 2015


    2015-04-29
    Venous (Vein) Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6609IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6609IDB
  • View Report: Research and Experts Market Report: Papillary Thyroid Cancer - Pipeline Review, H1 2015

    Papillary Thyroid Cancer - Pipeline Review, H1 2015


    2015-04-22
    Papillary Thyroid Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Papillary Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Papillary Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6640IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6640IDB
  • View Report: Research and Experts Market Report: Muscle Spasm - Pipeline Review, H1 2015

    Muscle Spasm - Pipeline Review, H1 2015


    2015-04-15
    Muscle Spasm - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Muscle Spasm - Pipeline Review, H1 2015’, provides an overview of the Muscle Spasm’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6662IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6662IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Metastatic Ovarian Cancer - Pipeline Review, H1 2015

    Metastatic Ovarian Cancer - Pipeline Review, H1 2015


    2015-03-26
    Metastatic Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6421IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6421IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H1 2015

    Rhabdomyosarcoma - Pipeline Review, H1 2015


    2015-03-19
    Rhabdomyosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6429IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6429IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Dermatitis - Pipeline Review, H1 2015

    Dermatitis - Pipeline Review, H1 2015


    2015-03-19
    Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6240IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6240IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015


    2015-02-28
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015’, provides...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6354IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6354IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-03-11
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6256IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6256IDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015


    2015-02-28
    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6268IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6268IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015


    2015-02-24
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6281IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6281IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2015

    Arterial Thrombosis - Pipeline Review, H1 2015


    2015-02-18
    Arterial Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6294IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6294IDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015


    2015-02-18
    Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Peripheral...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6290IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6290IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Oropharyngeal Candidiasis - Pipeline Review, H1 2015

    Oropharyngeal Candidiasis - Pipeline Review, H1 2015


    2015-02-10
    Oropharyngeal Candidiasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Oropharyngeal Candidiasis - Pipeline Review, H1 2015’, provides an overview of the Oropharyngeal Candidiasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6334IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6334IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2015

    Anxiety Disorders - Pipeline Review, H1 2015


    2015-02-10
    Anxiety Disorders - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6131IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6131IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Synovial Sarcoma - Pipeline Review, H1 2015

    Synovial Sarcoma - Pipeline Review, H1 2015


    2015-01-30
    Synovial Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Synovial Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Synovial Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6208IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6208IDB
  • View Report: Research and Experts Market Report: Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2015

    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2015


    2015-01-30
    Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H1 2015’, provides an overview of the Functional (Non Ulcer) Dyspepsia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6199IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6199IDB
  • View Report: Research and Experts Market Report: Down Syndrome - Pipeline Review, H1 2015

    Down Syndrome - Pipeline Review, H1 2015


    2015-01-30
    Down Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Down Syndrome - Pipeline Review, H1 2015’, provides an overview of the Down Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6186IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6186IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015


    2015-01-30
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6168IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6168IDB
  • View Report: Research and Experts Market Report: Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015

    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015


    2015-01-30
    Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015’, provides an overview of the Reflux Esophagitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6165IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6165IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-01-30
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6161IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6161IDB
  • View Report: Research and Experts Market Report: Epilepsy - Pipeline Review, H1 2015

    Epilepsy - Pipeline Review, H1 2015


    2015-01-30
    Epilepsy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6014IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6014IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2015

    Depression - Pipeline Review, H1 2015


    2015-01-30
    Depression - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6011IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6011IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Recurrent Malignant Glioma - Pipeline Review, H1 2015


    2015-01-22
    Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6070IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6070IDB
  • View Report: Research and Experts Market Report: Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015

    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015


    2015-01-22
    Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015’, provides an overview of the Elephantiasis (Lymphatic Filariasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6069IDB has a star rating of 2.9 out of 5
  • Go to More information on Report 05IB-GMDHC6069IDB
  • View Report: Research and Experts Market Report: Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015

    Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015


    2015-01-22
    Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6054IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6054IDB
  • View Report: Research and Experts Market Report: Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6029IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6029IDB
  • View Report: Research and Experts Market Report: Candidiasis - Pipeline Review, H1 2015

    Candidiasis - Pipeline Review, H1 2015


    2015-01-22
    Candidiasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H1 2015’, provides an overview of the Candidiasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6028IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6028IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H1 2015

    Dementia - Pipeline Review, H1 2015


    2015-01-22
    Dementia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2015’, provides an overview of the Dementia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6025IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6025IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H1 2015

    Brain Cancer - Pipeline Review, H1 2015


    2015-01-22
    Brain Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6024IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6024IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Reports: Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review

    Eisai Co Ltd (4523) - Financial and Strategic SWOT Analysis Review


    2017-02-22
    Eisai Co Ltd (Eisai) is one of the leading pharmaceutical companies in Japan. It undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs and pharmaceutical production systems, besides...
  • Company Reports
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH29032FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH29032FSA
  • View Report: Research and Experts Company Reports: Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review

    Sunesis Pharmaceuticals, Inc. (SNSS) - Financial and Strategic SWOT Analysis Review


    2016-10-12
    Sunesis Pharmaceuticals, Inc. (Sunesis), formerly Mosaic Pharmaceuticals, Inc., is a biopharmaceutical company. It develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's lead product candidate Qinpr...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH33264FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH33264FSA
  • View Report: Research and Experts Company Reports: Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review

    Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Nippon Kayaku Co., Ltd. (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UV-curing...
  • Company Reports
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH31776FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH31776FSA
  • View Report: Research and Experts Company Reports: Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review

    Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Takeda Pharmaceutical Company Limited (Takeda) is a research-based global pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health...
  • Company Reports
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH7835FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH7835FSA
  • View Report: Research and Experts Company Reports: Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review

    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review


    2017-03-21
    Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH18146FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH18146FSA
  • View Report: Research and Experts Company Reports: Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review

    Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review


    2016-05-03
    Northwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. Using its proprie...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH62423FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH62423FSA
  • View Report: Research and Experts Company Reports: Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

    Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Reports
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH27458FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH27458FSA
  • View Report: Research and Experts Market Report: Vitamin B12 Deficiency (Hypocobalaminemia) Global Clinical Trials Review, H2, 2015

    Vitamin B12 Deficiency (Hypocobalaminemia) Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Vitamin B12 Deficiency (Hypocobalaminemia) Global Clinical Trials Review, H2, 2015" provides an overview of Vitamin B12 Deficiency (Hypocobalaminemia) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2996CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC2996CTIDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015

    Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3022CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3022CTIDB
  • View Report: Research and Experts Industry Report: Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities

    Rx-OTC Switch Opportunities : Trends in OTC, category analysis, case studies and future opportunities


    2015-02-28
    After years of buoyant growth, the pharmaceutical industry is facing up to a more challenging time. With the growing cost of developing novel drugs, combined with rising regulatory pressures, the use of lifecycle management is playing an ever-more importa...
  • Industry Report
  • Cosmetics and Personal Care
  • Global
  • $2,795.00
  • Report 01GZ-CS1005IS has a star rating of 3.1 out of 5
  • Go to More information on Report 01GZ-CS1005IS
  • View Report: Research and Experts Project Profile: Eisai - Suzhou Oral Solid Dose (OSD) Production Facility - Jiangsu - Construction Project Profile

    Eisai - Suzhou Oral Solid Dose (OSD) Production Facility - Jiangsu - Construction Project Profile


    2015-08-12
    The "Eisai – Suzhou Oral Solid Dose (OSD) Production Facility – Jiangsu - Construction Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership...
  • Project Profile
  • Heavy Construction
  • China
  • $75.00
  • Report 00RW-CN17879PP has a star rating of 3.4 out of 5
  • Go to More information on Report 00RW-CN17879PP
  • View Report: Research and Experts Company Reports: Eisai Co., Ltd. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

    Eisai Co., Ltd. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report


    2013-04-19
    ICD Research's "Eisai Co., Ltd. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts...
  • Company Reports
  • Pharmaceuticals
  • Japan
  • $125.00
  • Report 01H3-ST08080CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-ST08080CP
  • View Report: Research and Experts Company Reports: Eisai Co., Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

    Eisai Co., Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


    2012-05-17
    ICD Research's "Eisai Co., Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business...
  • Company Reports
  • Pharmaceuticals
  • Japan
  • $125.00
  • Report 01H3-ST08106CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-ST08106CP
  • Industries and Sectors

    • Infectious Disease... (7)
    • Oncology (58)
    • Gastrointestinal... (14)
    • Immunology (2)
    • Central Nervous... (17)
    • Manufacturing and... (1)
    • Pharmaceuticals (136)
    • Life Sciences (87)
    • Ear Nose Throat... (1)
    • Cardiovascular (1)
    • Healthcare (9)
    • Genetic Disorders... (1)
    • Construction Materials... (21)
    • Medical Devices (1)
    • Cosmetics and Personal... (1)
    • Heavy Construction... (1)

    Geographic Regions

    • Global (343)
    • Panama (1)
    • Japan (8)
    • United States (5)
    • China (1)

    Report Types

    • Market Report (342)
    • Project Profile (3)
    • Company Reports (12)
    • Industry Report (1)

    Return to Company List

    Page created and rendered - Cache updated [4.62879s]

    --